Jessica Sachs

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jessica Sachs:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cogent Biosciences, Inc. Chief Medical Officer Common Stock 133,938 $5,183,400 $38.70 26 Dec 2025 Direct
Cogent Biosciences, Inc. Chief Medical Officer Stock Option (Right to Buy) 65,000 17 Dec 2025 Direct

Insider Reports Filed by Jessica Sachs

Symbol Company Period Transactions Value $ Form Type Role Filing Time
COGT Cogent Biosciences, Inc. 26 Dec 2025 1 -$3,198,245 4 Chief Medical Officer 30 Dec 2025, 16:01
COGT Cogent Biosciences, Inc. 17 Dec 2025 4 -$6,103,546 4 Chief Medical Officer 19 Dec 2025, 16:01
COGT Cogent Biosciences, Inc. 23 Jan 2025 1 $0 4 Chief Medical Officer 27 Jan 2025, 16:56
COGT Cogent Biosciences, Inc. 23 Jan 2024 1 $0 4 Chief Medical Officer 25 Jan 2024, 16:20
COGT Cogent Biosciences, Inc. 13 Feb 2023 1 $0 4 Chief Medical Officer 15 Feb 2023, 14:50
COGT Cogent Biosciences, Inc. 30 Jun 2022 1 +$4,600 4 Chief Medical Officer 01 Jul 2022, 09:19
COGT Cogent Biosciences, Inc. 25 Jan 2022 1 +$1,235,800 4 Chief Medical Officer 27 Jan 2022, 16:46
COGT Cogent Biosciences, Inc. 31 Dec 2021 1 +$4,595 4 Chief Medical Officer 04 Jan 2022, 20:25